Home
Research
Our publications

Our publications

These selected publications highlight the major themes of research at Mercy Perinatal. Further information on individual researchers and Obstetrics and Gynaecology Research at the University of Melbourne can be found here.

Comparison of Maternal Labor-Related Complications and Neonatal Outcomes Following Elective Induction of Labor at 39 Weeks of Gestation vs Expectant Management A Systematic Review and Meta-analysis

Hong J, Atkinson J, Roddy Mitchell A, Tong S, Walker SP, Middleton A, Lindquist A, Hastie R. JAMA Netw Open. 2023 May ...
Educational Outcomes for Children at 7 to 9 Years of Age After Birth at 39 vs 40 to 42 Weeks’ Gestation

Hiscock RJ, Atkinson JA, Tong S, Walker SP, Kennedy A, Cheong JYL, Quach JL, Gurrin LC, Hastie R, Lindquist A. JAMA ...
Plasma lipids are dysregulated preceding diagnosis of preeclampsia or delivery of a growth restricted infant.

Bartho LA, Keenan E, Walker SP, MacDonald TM, Nijagal B, Tong S, Kaitu'u-Lino TJ. EBioMedicine. 2023 Aug;94:104704. doi...
Circulating Chemerin Is Elevated in Women With Preeclampsia.

Bartho LA, Kandel M, Walker SP, Cluver CA, Hastie R, Bergman L, Pritchard N, Cannon P, Nguyen TV, Wong GP, MacDonald TM,...
Using the methylome to predict pre-eclampsia.

Kaitu'u-Lino TJ, Bartho LA, Tong S. Nat Med. 2023 Sep;29(9):2177-2178. doi: 10.1038/s41591-023-02499-x. PMID: 37640857.
Consumer Insights from a Feasibility Study on Remote and Extended Use of a Novel Non-Invasive Wearable Fetal Electrocardiogram Monitor.

Karmarkar D, Emerson Keenan, Brownfoot F. Nature Digital Medicine. Accepted for publication 9th April 2025
Rapid detection of fetal compromise using input length invariant deep learning on fetal heart rate signals.

Mendis L, Palaniswami M, Keenan E, Brownfoot F. Sci Rep 14, 12615 (2024). https://doi.org/10.1038/s41598-024-63108-6
Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.

Brownfoot FC, Hastie R, Hannan NJ, Cannon P, Tuohey L, Parry LJ, Senadheera S, Illanes SE, Kaitu’u-Lino, TJ, Tong S. Am...
Use of Metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind placebo controlled trial.

Cluver CA, Hiscock R, Decloedt EH, Hall DR, Schell S, Mol BW, Brownfoot F, Kaitu’u-Lino TJ, Walker SP, Tong S. BMJ 2021...
Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction.

Brownfoot FC, Hannan NJ, Cannon P, Nguyen V, Hastie R, Parry LJ, Senadheera S, Tuohey L, Tong S, Kaitu'u-Lino TJ. EBio...

Comparison of Maternal Labor-Related Complications and Neonatal Outcomes Following Elective Induction of Labor at 39 Weeks of Gestation vs Expectant Management A Systematic Review and Meta-analysis

Educational Outcomes for Children at 7 to 9 Years of Age After Birth at 39 vs 40 to 42 Weeks’ Gestation

Plasma lipids are dysregulated preceding diagnosis of preeclampsia or delivery of a growth restricted infant.

Circulating Chemerin Is Elevated in Women With Preeclampsia.

Using the methylome to predict pre-eclampsia.

Consumer Insights from a Feasibility Study on Remote and Extended Use of a Novel Non-Invasive Wearable Fetal Electrocardiogram Monitor.

Rapid detection of fetal compromise using input length invariant deep learning on fetal heart rate signals.

Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.

Use of Metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind placebo controlled trial.

Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction.

Sign up to get our latest updates